US Stock MarketDetailed Quotes
FBLG FibroBiologics
- 3.020
- +0.070+2.37%
Close Oct 31 16:00 ET
- 3.100
- +0.080+2.65%
Post 20:02 ET
106.48MMarket Cap-5075P/E (TTM)
3.070High2.750Low154.40KVolume2.980Open2.950Pre Close452.63KTurnover0.61%Turnover RatioLossP/E (Static)35.26MShares55.00052wk High-44.41P/B76.45MFloat Cap1.07852wk Low--Dividend TTM25.32MShs Float55.000Historical High--Div YieldTTM10.85%Amplitude1.078Historical Low2.931Avg Price1Lot Size
About FibroBiologics Company
FibroBiologics, Inc. engages in the development and commercialization of cell therapies. It focuses on treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. The firm’s product pipeline includes CybroCell, CYMS101, CYWC628, TCB190, and CYTER915. The company was founded by Peter O’Heeron on April 8, 2021 and is headquartered in Houston, TX.
Company Profile
SymbolFBLG
Company NameFibroBiologics
Listing DateJan 31, 2024
Founded2021
CEOMr. Peter O’Heeron
MarketNASDAQ
Employees10
Fiscal Year Ends12-31
Address455 East Medical Center Boulevard,Suite 300
CityHouston
ProvinceTexas
CountryUnited States of America
Zip Code77598
Phone1-281-671-5150
Company Executives
- Name
- Position
- Salary
- Peter O’Heeron
- Chairperson of the Board and Chief Executive Officer
- 4.29M
- Dr. Hamid Khoja, PhD
- Chief Scientific Officer
- 1.31M
- Robert E. Hoffman, C.P.A.
- Director, Interim Chief Financial Officer and Principal Accounting Officer
- 388.54K
- Stacy Ann Coen, M.B.A.
- Independent Director
- 384.54K
- Matthew Link
- Independent Director
- 379.54K
- Dr. Victoria Niklas, M.D.
- Independent Director
- 381.54K
- Richard C. Cilento, Jr,M.B.A.
- Independent Director
- 376.54K
- Ruben A. Garcia
- General Counsel
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data